Substance-Agnostic Potential
9:08–9:35 · 27s
New research suggests GLP-1s reduce cravings across opioids, cocaine, nicotine, and alcohol—possibly a first of its kind.


9:08–9:35 · 27s
New research suggests GLP-1s reduce cravings across opioids, cocaine, nicotine, and alcohol—possibly a first of its kind.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.